Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04737915 · ClinicalTrials.gov registry record · NA
Virtual Reality Exposure Versus In Vivo Exposure for Fear of Heights
A NA study, sponsored by University of Notre Dame.
- Completed
- Registry status
- NA
- Development phase
- 114
- Enrollment target
NCT04737915 is a NA study that has completed, run by University of Notre Dame. The registered enrollment target is 114 participants.
The verdict
NCT04737915, a NA study, has completed, sponsored by University of Notre Dame.
- COMPLETED
- Registry status
- NA
- Development phase
- 114 participants
- Enrollment target
Study Summary
This study randomly assigned 114 participants with significant fear of heights to one of three conditions: a) a single session of virtual reality exposure; b) a single session of in vivo exposure; or c) a control condition. The aim of this study was to compare the efficacy of virtual reality exposure to the efficacy of in vivo exposure or no exposure for participants with significant fear of heights.
Interventions
- BEHAVIORAL Exposure Therapy (In Vivo)
- BEHAVIORAL Exposure Therapy (Virtual Reality)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2018-06-11 |
| Est. Completion | 2019-03-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04737915
The ClinicalTrials.gov registry entry for NCT04737915 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Notre Dame, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Exposure Therapy (In Vivo) is the first listed.
NCT04737915 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04737915 about?
NCT04737915 is a clinical study titled "Virtual Reality Exposure Versus In Vivo Exposure for Fear of Heights". This study randomly assigned 114 participants with significant fear of heights to one of three conditions: a) a single session of virtual reality exposure; b) a single session of in vivo exposure; or c) a control condition. The aim of this study was to compare the efficacy of virtual reality exposur...
What is the current status of trial NCT04737915?
This trial is currently completed. It is a NA study. The enrollment target is 114 participants. The study started on 2018-06-11. Estimated completion is 2019-03-06.
What interventions are being tested in trial NCT04737915?
The interventions under investigation include: Exposure Therapy (In Vivo) (BEHAVIORAL), Exposure Therapy (Virtual Reality) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04737915?
This trial is sponsored by University of Notre Dame, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.